InsidersTradesSigma
Follow the 에이비프로바이오 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Industrials sector, 에이비프로바이오 has logged 1 public disclosures. Market capitalisation: €30.8bn. The latest transaction was disclosed on 16 March 2026 (Other). Among the most active insiders: 에이비프로바이오. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.